Sebastian Schellong

18.1k total citations · 4 hit papers
226 papers, 8.0k citations indexed

About

Sebastian Schellong is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Sebastian Schellong has authored 226 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Internal Medicine, 117 papers in Cardiology and Cardiovascular Medicine and 84 papers in Surgery. Recurrent topics in Sebastian Schellong's work include Venous Thromboembolism Diagnosis and Management (154 papers), Atrial Fibrillation Management and Outcomes (88 papers) and Diagnosis and Treatment of Venous Diseases (38 papers). Sebastian Schellong is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (154 papers), Atrial Fibrillation Management and Outcomes (88 papers) and Diagnosis and Treatment of Venous Diseases (38 papers). Sebastian Schellong collaborates with scholars based in Germany, United States and Canada. Sebastian Schellong's co-authors include Samuel Z. Goldhaber, Ajay K. Kakkar, Sam Schulman, Henry Eriksson, Clive Kearon, Patrick Mismetti, David Baanstra, Janet Schnee, Jeffrey Friedman and Harry R. Büller and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Sebastian Schellong

216 papers receiving 7.8k citations

Hit Papers

Dabigatran versus Warfarin in the Treatment of Acute Veno... 2009 2026 2014 2020 2009 2013 2013 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
    2009 1.9k citations Sam Schulman, Clive Kearon et al. profile →
  2. Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
    2013 713 citations Sam Schulman, Clive Kearon et al. profile →
  3. Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
    2013 688 citations Sam Schulman, Ajay K. Kakkar et al. Circulation profile →
  4. Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
    2013 436 citations Theodore E. Spiro, Harry R. Büller et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sebastian Schellong Germany 38 6.6k 5.5k 2.2k 1.2k 957 226 8.0k
Rupert Bauersachs Germany 43 4.9k 0.7× 4.7k 0.9× 2.2k 1.0× 1.3k 1.0× 1.1k 1.1× 228 7.5k
Philip Wells Canada 22 4.6k 0.7× 3.1k 0.6× 1.5k 0.7× 982 0.8× 860 0.9× 34 5.8k
Robert D. McBane United States 44 3.5k 0.5× 3.4k 0.6× 2.0k 0.9× 988 0.8× 687 0.7× 262 6.7k
Timothy A. Morris United States 25 5.3k 0.8× 3.7k 0.7× 1.7k 0.8× 952 0.8× 1.1k 1.2× 67 6.6k
Bruce L. Davidson United States 30 5.5k 0.8× 5.2k 0.9× 1.4k 0.7× 915 0.7× 616 0.6× 53 6.9k
Gary E. Raskob United States 24 5.7k 0.9× 5.1k 0.9× 1.5k 0.7× 1.5k 1.2× 949 1.0× 52 7.2k
Scott C. Woller United States 31 5.1k 0.8× 3.5k 0.6× 1.8k 0.8× 933 0.7× 1.8k 1.9× 103 7.3k
Sylvia Haas Germany 43 6.4k 1.0× 7.2k 1.3× 1.8k 0.8× 1.2k 1.0× 537 0.6× 209 9.1k
Nick van Es Netherlands 32 4.8k 0.7× 3.0k 0.6× 1.2k 0.5× 873 0.7× 1.2k 1.2× 132 6.7k
Susan Solymoss Canada 35 3.9k 0.6× 2.8k 0.5× 1.6k 0.7× 1000 0.8× 1.0k 1.1× 83 4.8k

Countries citing papers authored by Sebastian Schellong

Since Specialization
Citations

This map shows the geographic impact of Sebastian Schellong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Schellong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Schellong more than expected).

Fields of papers citing papers by Sebastian Schellong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Schellong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Schellong. The network helps show where Sebastian Schellong may publish in the future.

Co-authorship network of co-authors of Sebastian Schellong

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Schellong. A scholar is included among the top collaborators of Sebastian Schellong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Schellong. Sebastian Schellong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prandoni, Paolo, Meg Fluharty, Sebastian Schellong, et al.. (2025). Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry. European Journal of Internal Medicine. 144. 106492–106492.
2.
Birschmann, Ingvild, Simone Lindau, Stavros Konstantinides, et al.. (2025). Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients—Results of the Prospective RADOA Registry. Pharmaceuticals. 18(2). 170–170.
3.
Herrmann, Eva, Ingvild Birschmann, Simone Lindau, et al.. (2024). Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists—Results of the German Prospective RADOA-Registry. Journal of Clinical Medicine. 13(1). 272–272. 2 indexed citations
4.
Schellong, Sebastian, et al.. (2022). Deep vein thrombosis symptoms and 30-day mortality in acute pulmonary embolism. European Journal of Internal Medicine. 108. 43–51. 5 indexed citations
5.
Bikdeli, Behnood, Farès Moustafa, Alfred Ian Lee, et al.. (2022). Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism. Thrombosis Research. 211. 10–18. 6 indexed citations
6.
Bounameaux, Henri, Sylvia Haas, Alfredo E. Farjat, et al.. (2020). Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Thrombosis Research. 191. 103–112. 18 indexed citations
7.
8.
Goldhaber, Samuel Z., Ajay K. Kakkar, Sebastian Schellong, et al.. (2015). Abstract 12422: Influence of Polypharmacy on the Efficacy And Safety Of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER® and RE-COVER II™. Circulation. 1 indexed citations
9.
Schulman, Sam, Henry Eriksson, Samuel Z. Goldhaber, et al.. (2014). Abstract 18594: Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER™ and RE-COVER™ II. Circulation. 130. 4 indexed citations
10.
Cohen, Alexander T., Theodore E. Spiro, Alex C. Spyropoulos, et al.. (2014). D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. Journal of Thrombosis and Haemostasis. 12(4). 479–487. 90 indexed citations
11.
Trujillo‐Santos, Javier, et al.. (2013). Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function. The American Journal of Medicine. 126(5). 425–434.e1. 49 indexed citations
12.
Haas, Sylvia, Sebastian Schellong, Ulrich Tebbe, et al.. (2011). Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY. BMC Cancer. 11(1). 316–316. 31 indexed citations
13.
Gibson, Nadine Suzanne, Sebastian Schellong, Jan Beyer‐Westendorf, et al.. (2009). Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. Journal of Thrombosis and Haemostasis. 7(12). 2035–2041. 65 indexed citations
14.
Sternitzky, R, et al.. (2007). Struktur und Funktion des venösen Systems. Herz. 32(1). 3–9. 6 indexed citations
15.
Schellong, Sebastian, et al.. (2007). Etablierung eines Gefäßzentrums unter Nutzung gegebener Strukturen. PubMed. 101(3). 159–163. 1 indexed citations
16.
Schmidt, Benjamin & Sebastian Schellong. (2005). Management der Lungenembolie. Der Internist. 46(8). 899–912.
17.
Schmidt, Benjamin & Sebastian Schellong. (2003). Antikoagulation und Thromboseprophylaxe in passageren Risikosituationen bei Zustand nach ven�ser Thrombembolie. Medizinische Klinik. 98(8). 447–452. 1 indexed citations
18.
Schellong, Sebastian & T. Schwarz. (2002). Differenzialtherapie der tiefen Beinvenenthrombose. Der Internist. 43(1). 36–46. 1 indexed citations
19.
Schwarz, T., et al.. (1999). Popliteal entrapment syndrome: non-invasive diagnosis and complete recovery after surgery in an 11-year-old boy. Pediatric Radiology. 29(2). 109–111. 5 indexed citations
20.
Haubitz, Marion, et al.. (1997). Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody‐associated vasculitis. Arthritis & Rheumatism. 40(9). 1680–1684. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rupert Bauersachs Breakdown of academic impact, for papers by Philip Wells Breakdown of academic impact, for papers by Robert D. McBane Breakdown of academic impact, for papers by Timothy A. Morris Breakdown of academic impact, for papers by Bruce L. Davidson Breakdown of academic impact, for papers by Gary E. Raskob Breakdown of academic impact, for papers by Scott C. Woller Breakdown of academic impact, for papers by Sylvia Haas Breakdown of academic impact, for papers by Nick van Es Breakdown of academic impact, for papers by Susan Solymoss
Rankless by CCL
2026